Israel Biotech Fund
Stanley B. Fiel is a Venture Advisor at Israel Biotech Fund. Dr. Fiel is a distinguished physician and author of numerous published works on various topics relating to pulmonary and critical care medicine. Since 1978, Dr. Fiel has held key hospital appointments including Chief of the Division of Pulmonary / Critical Care Medicine at Drexel University College of Medicine and Hahnemann University in Philadelphia.
Dr. Fiel currently serves on the Advisory Board and Speaker’s Bureau with Pfizer, GlaxoSmithKline, Gilead, and Novartis. He has been a consultant for GlaxoSmithKline, Novartis, Pfizer, Gilead, and Vertex. He has received research grants from the NIH, Cystic Fibrosis Foundation, and various pharmaceutical companies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Israel Biotech Fund
Israel Biotech Fund seeks high-value returns by identifying and maximizing the success of therapeutic assets of Israel-based biotech companies. Their key asset is a unique team of 25 Venture Advisors, comprised of renowned industry leaders and professionals who, together with the fund’s managing partners, provide their portfolio companies with hands-on guidance and support.